Latest Royalty Income News

BTC Health has transformed its decade-long license agreement with Arna Pharma into an indefinite partnership, gaining royalties from Singapore and Malaysia sales and first rights to new pharmaceutical products in Australia and New Zealand.

Cazaly Resources reports solid exploration progress across copper, zinc, lithium, and rare earth projects in Australia, Namibia, and Canada, supported by a stable cash position of $3.8 million at December 2024.

Tombador Iron Limited reported a modest net cash outflow of $317,000 for the December 2024 quarter, yet holds robust cash reserves of $10.825 million, underpinning over 34 quarters of operational funding.

Tombador Iron Limited reports a modest cash increase and ongoing progress toward acquiring the Colomi Iron Project in Brazil, while managing royalty income from its sold Tombador project.

Hawthorn Resources has completed a pivotal Pre-Feasibility Study for its Mt Bevan Magnetite project and strategically converted its equity stake into a royalty, positioning the company for future value capture amid evolving market dynamics.

Acrux Limited has launched its Nitroglycerin 0.4% Ointment and successfully raised nearly $4 million, positioning the specialty pharma company for sustained revenue growth.

Gullewa Limited reports steady progress on its Hunter Valley subdivision and South Darlot gold exploration, alongside a significant royalty payment from Silver Lake Resources.

Fitzroy River Corporation's latest quarterly report reveals a dip in royalty income but highlights progress on major silver and gold projects, alongside strategic moves in energy royalties.

Lakes Blue Energy has completed the sale of its 49% stake in PEP 169, receiving $6.5 million and securing a 4% royalty on future production. The company now shifts focus to advancing drilling at its Wombat and Trifon/Gangell fields in the Gippsland Basin.